You are here:
LinkedIn-button

News

Check here for our latest news

Press Release

Intravacc announces positive pre-clinical data for its OMV-based Lyme vaccine Bilthoven, the Netherlands, 13 April 2021 – Intravacc, a world leader in translational research and development of preventive and therapeutic vaccines, today announced positive preclinical data for its OMV based Lyme…

Intravacc announces positive preclinical data for its OMV-based Lyme vaccine
  • Neisserial OMV based Lyme vaccine elicit high antibody titers in mice
  • Further evidence for Intravacc's versatile multi-disease OMV platform
  • Data are published in peer reviewed journal Vaccine
Read more

Press Release

Intravacc announces positive pre-clinical data for its SARS-CoV-2 nose spray vaccine Bilthoven, the Netherlands, 7 April 2021 – Intravacc, a global leader in translational research and development of viral and bacterial vaccines, today announced that it has obtained positive pre-clinical results…

Intravacc announces positive pre-clinical data for its SARS-CoV-2 nose spray vaccine
  • Intranasal administration of OMV-Spike protected against challenge with SARS-CoV-2
  • Intranasal vaccine administration has significant advantages over injectables
  • OMV technology is a powerful vaccine platform for future pandemics
Read more

Press Release

Intravacc Announces Appointment of Nathalie Laarakker as Chief Financial Officer Bilthoven, the Netherlands, 24 March 2021 – Intravacc, a world leader in translational research and development of vaccines, today announced the appointment of Nathalie Laarakker as Chief Financial Officer and member…

Intravacc Announces Appointment of Nathalie Laarakker as Chief Financial Officer
Read more

Press Release

Intravacc announces formation of Scientific Advisory Board Bilthoven, the Netherlands, 23 February 2021 – Intravacc, a world leader in translational research and development of vaccines, today announced the formation of a Scientific Advisory Board (“SAB”), chaired by Intravacc’s Chief Scientific…

Intravacc announces formation of Scientific Advisory Board
Read more

Press Release

Intravacc neemt moderne pilot productiefaciliteit in gebruik en start concept-design van multifunctionele vaccinfabriek Bilthoven, the Netherlands, 19 februari 2021 – Intravacc, wereldwijd vooraanstaand op het gebied van translationeel onderzoek naar en de ontwikkeling van vaccins, maakt bekend dat haar nieuwe moderne…

Intravacc neemt moderne pilot productiefaciliteit in gebruik en start concept-design van multifunctionele vaccinfabriek
  • Pilotfabriek geschikt voor productie van vaccins in klinische fase I & II onderzoek
  • Consortium werkt plan uit voor nieuwe multifunctionele vaccinfabriek
  • Uitgebreide omgevingsvergunningen maken snelle realisatie mogelijk
Read more

Press Release

Dutch Intravacc starts concept design for multifunctional, high-capacity vaccine plant for national requirement New state-of-the-art pilot vaccine production facility ready for use   Bilthoven, the Netherlands, 19 February 2021 – Intravacc, a world leader in translational research and development of…

Dutch Intravacc starts concept design for multifunctional, high-capacity vaccine plant for national requirement
  • New pilot plant for production of vaccine candidates in clinical phase I & II research
  • Consortium starts concept design for new multifunctional vaccine factory that can produce enough vaccines for the Netherlands during pandemic
  • Extensive environmental permits already in place will enable rapid construction
Read more
LinkedIn-button

NEED MORE INFORMATION?

Contact our
specialist

A team of 140+ specialists is at your disposal here in Bilthoven. Contact us to see how we can bring your vaccine concept ready for in-human trials.

CONTACT

Subscribe to our news update

Stay up to date with the latest developments, and be the first to receive our news updates and announcements.